
Pimavaserin May Solve The Problem of Antipsychotics in Dementia
The off-label use of current antipsychotic medications for dementia is linked to increased mortality, serious adverse events, and cognitive decline. Learn how the pimavanserin trial

The off-label use of current antipsychotic medications for dementia is linked to increased mortality, serious adverse events, and cognitive decline. Learn how the pimavanserin trial

Penn State’s Professor Chen has developed an innovative model of regenerating neurons in Alzheimer’s. Learn how Dr. Chen hopes to develop this further in the

A proven approach to slow the aging process and associated diseases is dietary restriction. New research helps explain the action of a drug that appears

RESEARCH VIDEO See how the U.S. government’s NIH sets the pace of America’s dementia research. Learn about their strategies, agendas and the initiatives they empower.

Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to

VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can

VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called

Alzheimer’s is the most common type of dementia, but there are many others. Should Gulf War Illness, which effects over 250,000 troops deployed in the

Top experts at world-renowned Johns Hopkins Medicine did a systematic review of existing statin studies. Unlike the FDA, they found no connection between short-term statin

Pramlintide (known by the brand name Symlin®, an FDA-approved diabetic drug) reduces Alzheimer’s amyloid-beta peptides in the lab. Learn how it improves learning and memory.

VIDEO: See why the
wonderful Alzheimer’s activities program, “Creative Aging: Dance Like Nobody’s Watching” has been a smash success for people with Alzheimer’s, as well as caregivers.

Knowing when to bring in help — and how to manage it well — can make all the difference in caring for a loved one with dementia. The right timing protects safety and dignity, while good management preserves peace of mind for everyone involved.

A new groundbreaking MRI study reveals how the brain’s “nightly cleaning crew” depends on quality sleep. When we rest deeply, brain fluids clear away toxins — protecting memory and cutting dementia risk.

Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.

Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.

Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.

A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.
No spam, only news and updates.


